BioWorld: The Daily Biopharmaceutical and Medical Technology …
Ring Therapeutics Inc. has joined forces with Singapore’s Agency for Science, Technology, and Research and with the Singapore Eye Research Institute to advance the first... In the newest …
BioWorld: The Daily Biopharmaceutical News Source
Biopharma deal activity in October totaled $22.31 billion, marking a 72% jump from $13.01 billion in September. Year-to-date deal values have decreased by 2%, from $175.29 billion during the …
Novo Nordisk wins first FDA approval for long-acting human
2020年9月1日 · The first weekly therapy for adult growth hormone deficiency (GHD) has arrived in the U.S. with FDA approval for Novo Nordisk A/S' Sogroya (somapacitan). It’s the first of …
GI Dynamics enrolls first patient in pivotal Endobarrier trial
GI Dynamics Inc.’s U.S. IDE trial of Endobarrier, which is designed for patients diagnosed with type 2 diabetes and obesity, is now underway with the first patient enrollment at Michigan …
Coronavirus - Articles - BioWorld
2024年11月12日 · The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note that we …
China - Articles - BioWorld
2024年11月6日 · Oct. 21, 2024. By Tamra Sami. No Comments. After raising $42 million in a series C1 round, Lanova Medicines Ltd. is advancing its lead phase III antibody-drug …
Patents - Articles - BioWorld
3 天之前 · Voronoi discloses new EGFR mutant inhibitors. Voronoi Inc. has discovered EGFR (Leu858Arg/Thr790Met/Cys797Ser triple mutant) and EGFR (del19/Thr790Met/Cys797Ser …
| BioWorld
1992年5月14日 · Scios Inc. and Nova Pharmaceutical Corp. announced onWednesday that they will merge in an exchange of stockvalued at $180 million. The company, to be called Scios …
Nuala Moran - BioWorld
2024年10月3日 · By Nuala Moran. No Comments. In one of the largest private rounds raised by an Italian biotech, Genespire Srl has closed a €46.6 million (US$51.88 million) series B, …
Deals - BioWorld
2024年9月6日 · Epimab licenses BCMA bispecific to startup Vignette in $635M deal. In a deal that brings $60 million in cash and equity up front, plus up to $575 million in milestone payments, …